EUVIMEDEUVIMED entdecken
Systematische Übersicht

Survival Outcomes of Head and Neck Neuroendocrine Carcinoma: A Systematic Review

Morena Aïta iD, Ilario Galofaro iD, Antonino Maniaci iD, Jerome R Lechien iD

Head & Neck · 2026

DOI: 10.1002/hed.70402 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Head & Neck, 2026. Verfasst von Morena Aïta und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Mons (UMONS), Mons, Belgium. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Head and Neck Neoplasms. Die Arbeit nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This systematic review investigated pathological, oncological, and survival outcomes of Head and neck neuroendocrine carcinoma (HNNEC).

Methods

Three independent investigators conducted a PRISMA‐compliant literature search. Primary outcomes included tumor stage, overall survival (OS), disease‐free survival, recurrence, metastasis, and therapeutic strategies.

Results

The most common locations were the larynx ( n = 1041), sinonasal tract ( n = 917), and oropharynx ( n = 366), mostly cT2/cT4 and cN0/cN2. Small‐cell carcinoma predominated ( n = 2334). Laryngeal tumors were preferentially treated by surgery plus radiotherapy, sinonasal/nasopharyngeal tumors by chemoradiotherapy, and salivary tumors by surgery with adjuvant therapy. Surgical cohorts achieved 5‐year OS of 33.0%–73.9%, and multimodal CRT‐plus‐surgery 57.2%–61.0%. Laryngeal and mucosal tumors had more favorable outcomes than sinonasal/salivary localizations; well/moderately‐differentiated carcinoids outperformed poorly‐differentiated and small‐cell variants (median OS < 24 months).

Conclusion

HNNEC survival strongly depends on histology, site, and treatment modality. Substantial therapeutic heterogeneity reflects the lack of guidelines, highlighting the need for standardized, histology‐ and site‐specific management recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, NeuroendocrineHead and Neck NeoplasmsHumansDisease-Free SurvivalNeoplasm StagingNeoplasm Recurrence, LocalSurvival AnalysisFemaleCombined Modality TherapyMaleTreatment Outcome

Stichwörter der Autor:innen

cancercarcinomahead and neckneuroendocrineotolaryngologyotorhinolaryngology

Autor:innen und Institutionen

  • Department of Surgery, University of Mons (UMONS), Mons, Belgium.
  • Department of Medicine and Surgery, Enna Kore University, Enna, Italy.
  • Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, Paris Saclay University, Paris, France.
  • Department of Otolaryngology-Head and Neck Surgery, CHU Saint-Pierre, Brussels, Belgium.

ORCID-Profile: Morena Aïta, Ilario Galofaro, Antonino Maniaci, Jerome R Lechien

Zitieren

APA

Aïta, M., Galofaro, I., Maniaci, A., & Lechien, J. R. (2026). Survival Outcomes of Head and Neck Neuroendocrine Carcinoma: A Systematic Review. Head & Neck. https://doi.org/10.1002/hed.70402

Vancouver

Aïta M, Galofaro I, Maniaci A, Lechien JR. Survival Outcomes of Head and Neck Neuroendocrine Carcinoma: A Systematic Review. Head & Neck. 2026. doi:10.1002/hed.70402

BibTeX
@article{Ata2026,
  author = {Aïta, Morena and Galofaro, Ilario and Maniaci, Antonino and Lechien, Jerome R},
  title = {Survival Outcomes of Head and Neck Neuroendocrine Carcinoma: A Systematic Review},
  journal = {Head & Neck},
  year = {2026},
  doi = {10.1002/hed.70402}
}
Kostenlos starten →